Folgen
Mark Jit
Titel
Zitiert von
Zitiert von
Jahr
Social contacts and mixing patterns relevant to the spread of infectious diseases
J Mossong, N Hens, M Jit, P Beutels, K Auranen, R Mikolajczyk, ...
PLoS Med 5 (3), e74, 2008
29512008
Estimated transmissibility and impact of SARS-CoV-2 lineage B. 1.1. 7 in England
NG Davies, S Abbott, RC Barnard, CI Jarvis, AJ Kucharski, JD Munday, ...
Science 372 (6538), eabg3055, 2021
2624*2021
The effect of control strategies to reduce social mixing on outcomes of the COVID-19 epidemic in Wuhan, China: a modelling study
K Prem, Y Liu, TW Russell, AJ Kucharski, RM Eggo, N Davies, S Flasche, ...
The Lancet Public Health 5 (5), e261-e270, 2020
23742020
Age-dependent effects in the transmission and control of COVID-19 epidemics
NG Davies, P Klepac, Y Liu, K Prem, M Jit, RM Eggo
Nature Medicine 26, 1205–1211, 2020
18532020
Challenges in ensuring global access to COVID-19 vaccines: production, affordability, allocation, and deployment
OJ Wouters, KC Shadlen, M Salcher-Konrad, AJ Pollard, HJ Larson, ...
The Lancet 397 (10278), 1023-1034, 2021
11382021
Global, regional, and national estimates of the population at increased risk of severe COVID-19 due to underlying health conditions in 2020: a modelling study
A Clark, M Jit, C Warren-Gash, B Guthrie, HHX Wang, SW Mercer, ...
The Lancet Global Health 8 (8), e1003-e1017, 2020
10372020
Projecting social contact matrices in 152 countries using contact surveys and demographic data.
K Prem, AR Cook, M Jit
PLoS computational biology 13 (9), e1005697, 2017
8532017
Cross-protective efficacy of two human papillomavirus vaccines: a systematic review and meta-analysis
T Malagón, M Drolet, MC Boily, EL Franco, M Jit, J Brisson, M Brisson
The Lancet infectious diseases 12 (10), 781-789, 2012
5222012
Impact of HPV vaccination and cervical screening on cervical cancer elimination: a comparative modelling analysis in 78 low-income and lower-middle-income countries
M Brisson, JJ Kim, K Canfell, M Drolet, G Gingras, EA Burger, D Martin, ...
The Lancet 395 (10224), 575-590, 2020
4992020
Routine childhood immunisation during the COVID-19 pandemic in Africa: a benefit–risk analysis of health benefits versus excess risk of SARS-CoV-2 infection
K Abbas, SR Procter, K van Zandvoort, A Clark, S Funk, T Mengistu, ...
The Lancet Global Health 8 (10), e1264-e1272, 2020
3522020
Economic evaluation of human papillomavirus vaccination in the United Kingdom
M Jit, YH Choi, WJ Edmunds
Bmj 337, 2008
3372008
The impact of non-pharmaceutical interventions on SARS-CoV-2 transmission across 130 countries and territories
Y Liu, C Morgenstern, J Kelly, R Lowe, M Jit
BMC medicine 19 (1), 1-12, 2021
3062021
Population-level impact, herd immunity, and elimination after human papillomavirus vaccination: a systematic review and meta-analysis of predictions from transmission-dynamic …
M Brisson, É Bénard, M Drolet, JA Bogaards, I Baussano, S Vänskä, M Jit, ...
The Lancet Public Health 1 (1), e8-e17, 2016
2782016
COVID-19 vaccine challenges: What have we learned so far and what remains to be done?
R Forman, S Shah, P Jeurissen, M Jit, E Mossialos
Health Policy 125 (5), 553-567, 2021
2762021
Cost-effectiveness of female human papillomavirus vaccination in 179 countries: a PRIME modelling study
M Jit, M Brisson, A Portnoy, R Hutubessy
The Lancet Global Health 2 (7), e406-e414, 2014
2712014
The burden of influenza in England by age and clinical risk group: A statistical analysis to inform vaccine policy
D Cromer, AJ van Hoek, M Jit, WJ Edmunds, D Fleming, E Miller
Journal of Infection 68 (4), 363-371, 2014
2482014
Effect of internationally imported cases on internal spread of COVID-19: a mathematical modelling study
TW Russell, JT Wu, S Clifford, WJ Edmunds, AJ Kucharski, M Jit
The Lancet Public Health 6 (1), e12-e20, 2020
2092020
Vaccination against pandemic influenza A/H1N1v in England: a real-time economic evaluation
M Baguelin, AJ Van Hoek, M Jit, S Flasche, PJ White, WJ Edmunds
Vaccine 28 (12), 2370-2384, 2010
2062010
Public health impact and cost-effectiveness of the RTS, S/AS01 malaria vaccine: a systematic comparison of predictions from four mathematical models
MA Penny, R Verity, CA Bever, C Sauboin, K Galactionova, S Flasche, ...
The Lancet 387 (10016), 367-375, 2016
2012016
The long-term safety, public health impact, and cost-effectiveness of routine vaccination with a recombinant, live-attenuated dengue vaccine (Dengvaxia): a model comparison study
S Flasche, M Jit, I Rodríguez-Barraquer, L Coudeville, M Recker, K Koelle, ...
PLoS medicine 13 (11), e1002181, 2016
1852016
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20